- Home
- ALT vs VERI Comparison
ALT vs VERI Comparison
Compare ALT & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | VERI |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.0M | 537.1M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | ALT | VERI |
|---|---|---|
| Price | $5.45 | $5.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $16.33 | $10.00 |
| AVG Volume (30 Days) | 3.5M | ★ 3.7M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $20,000.00 | ★ $98,027,000.00 |
| Revenue This Year | N/A | $20.68 |
| Revenue Next Year | N/A | $18.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.74 |
| 52 Week Low | $2.90 | $1.22 |
| 52 Week High | $9.59 | $9.42 |
Technical Indicators
Market Signals| Indicator | ALT | VERI |
|---|---|---|
| Relative Strength Index (RSI) | 62.89 | 51.59 |
| Support Level | $5.03 | $5.18 |
| Resistance Level | $6.03 | $6.13 |
| Average True Range (ATR) | 0.38 | 0.39 |
| MACD | -0.00 | 0.13 |
| Stochastic Oscillator | 55.52 | 63.53 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.